Home Biosimilar Antibodies Proteases Thrombin antibody Befovacimab (Anti-TFPI) For research use only.
Not for use in humans.

Befovacimab (Anti-TFPI)

Synonyms: BAY 1093884

Befovacimab (anti-TFPI) is a fully human monoclonal IgG2 antibody able to bind to tissue factor pathway inhibitors (TFPI) with the potential to be used in  haemophilia A/B research. MW: 143.24 kD.

Befovacimab (Anti-TFPI)

Purity & Quality Control

≥99

Choose Selective Thrombin Inhibitors

Biological Activity

Description Befovacimab (anti-TFPI) is a fully human monoclonal IgG2 antibody able to bind to tissue factor pathway inhibitors (TFPI) with the potential to be used in  haemophilia A/B research. MW: 143.24 kD.

Product Details

CAS No. 2156634-62-5
Molecular Weight 143.24
Isotype Human IgG2SA
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Befovacimab (Anti-TFPI) | Befovacimab (Anti-TFPI) supplier | purchase Befovacimab (Anti-TFPI) | Befovacimab (Anti-TFPI) cost | Befovacimab (Anti-TFPI) manufacturer | order Befovacimab (Anti-TFPI) | Befovacimab (Anti-TFPI) distributor